Science & Enterprise subscription

Follow us on Twitter

  • Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as w… https://t.co/XDS3u9zDEX
    about 17 hours ago
  • New post on Science and Enterprise: MIT Spins-Off 32 Start-Ups in 2018 https://t.co/MwJpYlGhwV #Science #Business #AAASmtg
    about 17 hours ago
  • New contributed post on Science and Enterprise: https://t.co/MCiZyaoc0I Ships Are Becoming Safer With Technology
    about 20 hours ago
  • A panel of data and behavioral scientists envision great potential for blockchain in science, but show few cases o… https://t.co/Ch0yJRek4W
    about 2 days ago
  • New post on Science and Enterprise: Blockchain and Science, Not Ready for Prime Time https://t.co/mYiRQ0j8vU #Science #Business #AAASmtg
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Algorithms Identify More Genetic Syndromes

Data and person graphic

An analysis of facial images with computer vision and deep learning returned more accurate identifications of genetic syndromes than 3 panels of trained clinicians . . . → Read More: Algorithms Identify More Genetic Syndromes

Tissue Chip, A.I. Companies Partner on Heart Drug Discovery

Heart check

A developer of chip devices emulating heart tissue and a medical analytics company using artificial intelligence are jointly discovering new drugs to treat aging heart muscles. . . . → Read More: Tissue Chip, A.I. Companies Partner on Heart Drug Discovery

AI, Wearables Posing Health Privacy Risks

Operating a smart watch

An analysis shows artificial intelligence algorithms can connect Americans’ activity tracking data to to their individual private medical information. . . . → Read More: AI, Wearables Posing Health Privacy Risks

Drug Discovery Start-Up Gains $400M Financing

Glasses, computer screens

A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank. . . . → Read More: Drug Discovery Start-Up Gains $400M Financing

Virtual Reality Illness Fix in Development

Man in virtual reality headset

A computer science and engineering team in Texas is developing a technical solution for virtual reality experiences that can make some users physically ill, with symptoms like seasickness. . . . → Read More: Virtual Reality Illness Fix in Development

A.I.-Aided Processes Reduce Chemical Reaction Time, Waste

Ryan Hartman

A chemical engineering lab designed processes with artificial intelligence to screen chemical reactions in small quantities that can reduce the time and waste in current methods. . . . → Read More: A.I.-Aided Processes Reduce Chemical Reaction Time, Waste

Companies to Analyze 40,000 Protein Samples

DNAmolcule model

A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples. . . . → Read More: Companies to Analyze 40,000 Protein Samples

Validation Scheme Proposed for Medical Algorithms

Biocircuits illustration

A law school professor urges developers, users, and regulators of machine learning in medicine to validate the algorithms that represent their underlying decision-making processes. . . . → Read More: Validation Scheme Proposed for Medical Algorithms

Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study

Inspecting lung X-rays

A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease. . . . → Read More: Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study

Project to Catalog Precision Lung Cancer Immunotherapies

Lung cancer development

A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer. . . . → Read More: Project to Catalog Precision Lung Cancer Immunotherapies